Skip to main content

Table 4 Multivariate analysis of potential risk factors associated with hepatitis in HBsAg-negative DLBCL patients

From: Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival

Variate

OR

95% CI

P value

HBcAb (+)

3.27

1.25-8.59

0.016

ALT (>40 U/L)

4.22

1.43-12.49

0.009

AST(>45 U/L)

NA

NA

0.129

  1. OR, odds ratio; CI, confidence interval; NA, not applicable. Other abbreviations as in Table 1.
Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us